FI920720A0 - 4-PYRIMIDINONDERIVAT, FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA I TERAPI. - Google Patents

4-PYRIMIDINONDERIVAT, FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA I TERAPI.

Info

Publication number
FI920720A0
FI920720A0 FI920720A FI920720A FI920720A0 FI 920720 A0 FI920720 A0 FI 920720A0 FI 920720 A FI920720 A FI 920720A FI 920720 A FI920720 A FI 920720A FI 920720 A0 FI920720 A0 FI 920720A0
Authority
FI
Finland
Prior art keywords
alkyl
optionally substituted
dessa
ring
branched
Prior art date
Application number
FI920720A
Other languages
Finnish (fi)
Other versions
FI920720A (en
Inventor
Christian Hoornaert
Marc Daumas
Michel Aletru
Jean-Claude Muller
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI920720A0 publication Critical patent/FI920720A0/en
Publication of FI920720A publication Critical patent/FI920720A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Abstract

1. Compounds, existing in three tautomeric forms, corresponding to the general formulae (I), (I') and (I'') <IMAGE> in which R1 = linear or branched (C1-7)alkyl, linear or branched (C3-9)alkenyl, cyclo(C3-7)alkyl(C1-6)alkyl, R2 = H, linear or branched (C1-7)alkyl, cyclo(C3-7)alkyl(C1-3)alkyl, aryl(C1-3)alkyl optionally substituted in the ring, aryloxy(C1-3)alkyl optionally substituted in the ring, arylthio(C1-3)alkyl optionally substituted in the ring, arylsulphonyl(C1-3)alkyl optionally substituted in the ring, heteroaryl(C1-3)alkyl optionally substituted in the ring, R3 = CO2H 1H-tetrazol-5-yl, NHCOR11, NHSO2R11, CONHSO2R11, CONHOR12, where R11 = CH3, CF3 or optionally substituted phenyl, R12 = H, CH3 or optionally substituted phenyl, as well as their pharmaceutically acceptable organic or inorganic salts. Therapeutic application.t
FI920720A 1991-02-20 1992-02-19 4-PYRIMIDINONDERIVAT, FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA ITERAPI FI920720A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9102032A FR2672892B1 (en) 1991-02-20 1991-02-20 DERIVATIVES OF 4-PYRIMIDINONES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.

Publications (2)

Publication Number Publication Date
FI920720A0 true FI920720A0 (en) 1992-02-19
FI920720A FI920720A (en) 1992-08-21

Family

ID=9409925

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920720A FI920720A (en) 1991-02-20 1992-02-19 4-PYRIMIDINONDERIVAT, FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA ITERAPI

Country Status (23)

Country Link
EP (1) EP0500409B1 (en)
JP (1) JP2529798B2 (en)
KR (1) KR920016434A (en)
CN (1) CN1034171C (en)
AT (1) ATE135695T1 (en)
AU (1) AU650319B2 (en)
CA (1) CA2061456A1 (en)
CS (1) CS49092A3 (en)
DE (1) DE69209113T2 (en)
DK (1) DK0500409T3 (en)
ES (1) ES2086090T3 (en)
FI (1) FI920720A (en)
FR (1) FR2672892B1 (en)
GR (1) GR3019404T3 (en)
HU (2) HUT60477A (en)
IE (1) IE76145B1 (en)
IL (1) IL101014A (en)
MX (1) MX9200690A (en)
NO (1) NO920648L (en)
NZ (1) NZ241659A (en)
PL (1) PL168617B1 (en)
RU (1) RU2073675C1 (en)
ZA (1) ZA921203B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them
FR2700543B1 (en) * 1993-01-15 1995-03-17 Synthelabo Salts of 4-pyrimidinone derivatives, their preparation and their therapeutic use.
SE9903028D0 (en) 1999-08-27 1999-08-27 Astra Ab New use
CA2688161C (en) 2007-06-04 2020-10-20 Kunwar Shailubhai Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2522968T3 (en) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (en) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others
MX2011008058A (en) * 2009-01-30 2011-09-01 Takeda Pharmaceutical Fused ring compound and use thereof.
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
JP2550442B2 (en) * 1989-06-30 1996-11-06 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー Substituted imidazole
EP0407342A3 (en) * 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
EP0424317A3 (en) * 1989-10-19 1991-09-25 Ciba-Geigy Ag Pyrimidines
EP0435827A3 (en) * 1989-12-28 1991-11-13 Ciba-Geigy Ag Diaza compounds
JPH05505609A (en) * 1990-03-30 1993-08-19 メルク・エンド・カムパニー・インコーポレーテツド Substituted pyrimidines, pyrimidinones and pyridrimidines
IE912114A1 (en) * 1990-07-02 1992-01-15 Union Pharma Scient Appl Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present

Also Published As

Publication number Publication date
IE76145B1 (en) 1997-10-08
DE69209113D1 (en) 1996-04-25
HUT60477A (en) 1992-09-28
FR2672892A1 (en) 1992-08-21
EP0500409B1 (en) 1996-03-20
NZ241659A (en) 1993-03-26
IL101014A (en) 1996-06-18
PL168617B1 (en) 1996-03-29
IE920525A1 (en) 1992-08-26
CS49092A3 (en) 1992-09-16
NO920648L (en) 1992-08-21
IL101014A0 (en) 1992-11-15
RU2073675C1 (en) 1997-02-20
CN1034171C (en) 1997-03-05
MX9200690A (en) 1992-08-01
ZA921203B (en) 1992-11-25
ATE135695T1 (en) 1996-04-15
JP2529798B2 (en) 1996-09-04
DK0500409T3 (en) 1996-07-15
HU9200532D0 (en) 1992-05-28
GR3019404T3 (en) 1996-06-30
DE69209113T2 (en) 1996-10-31
FR2672892B1 (en) 1994-01-14
PL293531A1 (en) 1992-08-24
AU1105992A (en) 1992-08-27
ES2086090T3 (en) 1996-06-16
FI920720A (en) 1992-08-21
EP0500409A1 (en) 1992-08-26
AU650319B2 (en) 1994-06-16
CN1064269A (en) 1992-09-09
HU211886A9 (en) 1995-12-28
CA2061456A1 (en) 1992-08-21
NO920648D0 (en) 1992-02-19
KR920016434A (en) 1992-09-24
JPH04346980A (en) 1992-12-02

Similar Documents

Publication Publication Date Title
FI920720A0 (en) 4-PYRIMIDINONDERIVAT, FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA I TERAPI.
FI924869A0 (en) KINOLINDERIVAT, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH TERAPEUTISK ANVAENDNING AV DESSA
FI915970A0 (en) CEILING MODEL, SOM AER NYTTIGA VID VAORD AV CANCER OCH SOM HAR ANTIHISTAMINEGENSKAPER.
DE69410509T2 (en) Benzoxazine derivatives, their preparation and their use in therapy
ATE166875T1 (en) ELLIPTICINE DERIVATIVES WITH ANTI-TUMOR EFFECT
FI912888A0 (en) 2- (AMINOALKYL) -5- (ARYLALKYL) -1,3-DIOXANDERS, DERAS FRAMSTAELLNING OCH THERAPEUTIC TILLAEMPNING.
FI910511A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV SUBSTITUERADE B-DIKETONER.
ES2190941T3 (en) DERIVATIVES OF BENCILAMINODIACETAMIDAS, COMPOSITIONS, COMPOSITIONS THAT INCLUDE THEM, PREPARATION PROCEDURE AND USE.
FI942265A0 (en) 2-aminopyrazine-5-carboxamide derivatives, their preparation and therapeutic use
FI933468A (en) Tetrahydronaphthalene derivatives, framstaellning av dessa och therapeutisk anvaendning av dessa
ATE148462T1 (en) ISOXAZOLE DERIVATIVES AS LIGHT PROTECTIVE AGENTS
FI914138A0 (en) CEILINGS, VILKA INNEHAOLLER SUBSTITUERADE 2-CYKLOHEXENDERIVAT OCH DERAS ANVAENDNING VID VAORD AV SJUKDOMAR.